Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2026-01-11 @ 3:40 PM
Study NCT ID:
NCT02711202
Status:
COMPLETED
Last Update Posted:
2025-06-04
First Post:
2016-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Sponsor:
Institute for Clinical and Experimental Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-09
First Submit QC Date:
None
Study First Post Date:
2016-03-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-04-29
Results First Submit QC Date:
None
Results First Post Date:
2025-06-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-02
Last Update Post Date:
2025-06-04
Last Update Post Date Type:
ACTUAL